Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials

This systematic review and meta-analysis (PROSPERO registration; ref CRD 42020198921) aimed to govern photobiomodulation therapy (PBMT) efficacy in temporomandibular disorder (TMD). PRISMA guidelines and Cochrane Collaboration recommendations were followed. Differences in pain reduction assessment b...

Full description

Bibliographic Details
Main Authors: Reem Hanna, Snehal Dalvi, René Jean Bensadoun, Stefano Benedicenti
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/7/1028
_version_ 1797528705296236544
author Reem Hanna
Snehal Dalvi
René Jean Bensadoun
Stefano Benedicenti
author_facet Reem Hanna
Snehal Dalvi
René Jean Bensadoun
Stefano Benedicenti
author_sort Reem Hanna
collection DOAJ
description This systematic review and meta-analysis (PROSPERO registration; ref CRD 42020198921) aimed to govern photobiomodulation therapy (PBMT) efficacy in temporomandibular disorder (TMD). PRISMA guidelines and Cochrane Collaboration recommendations were followed. Differences in pain reduction assessment by qualitative measurement with visual analogue scale (VAS), pain pressure threshold (PPT) and maximum mouth opening (MMO) were calculated with 95% confidence intervals and pooled in a random effects model with a subgroup analysis, evaluating the role of follow-up duration. Heterogeneity was analysed using Q and I<sup>2</sup> tests. Publication bias was assessed by visual examination of funnel plot symmetry. Qualitative analysis revealed 46% of the 44 included studies showed a high risk of bias. Meta-analysis on 32 out of 44 studies revealed statistically significant intergroup differences (SSID) for VAS (SMD = −0.55; 95% CI = −0.82 to −0.27; Z = 3.90 (<i>p</i> < 0.001)), PPT (SMD = −0.45; 95% CI = −0.89 to 0.00; Z = 1.97 (<i>p</i> = 0.05)) and MMO (SMD = −0.45; 95% CI = −0.89 to 0.00; Z = 1.97 (<i>p</i> = 0.05)), favouring PBMT compared to control treatment strategies. Sensitivity analysis revealed SSID (SMD = −0.53; 95% CI = −0.73 to −0.32; Z = 5.02 (<i>p</i> < 0.0001)) with low heterogeneity (Τ<sup>2</sup> = 0.02; χ<sup>2</sup> = 16.03 (<i>p</i> = 0.31); I<sup>2</sup> = 13%). Hence, this review, for first time, proposed suggested recommendations for PBMT protocols and methodology for future extensive TMD research.
first_indexed 2024-03-10T10:03:10Z
format Article
id doaj.art-f68183cf233c41299847bf3117f50f66
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T10:03:10Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-f68183cf233c41299847bf3117f50f662023-11-22T01:48:02ZengMDPI AGAntioxidants2076-39212021-06-01107102810.3390/antiox10071028Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled TrialsReem Hanna0Snehal Dalvi1René Jean Bensadoun2Stefano Benedicenti3Department of Surgical Sciences and Integrated Diagnostics, Laser Therapy Centre, University of Genoa, Viale Benedetto XV 6, 16132 Genoa, ItalyDepartment of Periodontology, Swargiya Dadasaheb Kalmegh Smruti Dental College and Hospital, Nagpur 441110, IndiaDepartment of Oncology Radiology, Centre De Haute Energie, 10 Boulevard Pasteur, 06000 Nice, FranceDepartment of Surgical Sciences and Integrated Diagnostics, Laser Therapy Centre, University of Genoa, Viale Benedetto XV 6, 16132 Genoa, ItalyThis systematic review and meta-analysis (PROSPERO registration; ref CRD 42020198921) aimed to govern photobiomodulation therapy (PBMT) efficacy in temporomandibular disorder (TMD). PRISMA guidelines and Cochrane Collaboration recommendations were followed. Differences in pain reduction assessment by qualitative measurement with visual analogue scale (VAS), pain pressure threshold (PPT) and maximum mouth opening (MMO) were calculated with 95% confidence intervals and pooled in a random effects model with a subgroup analysis, evaluating the role of follow-up duration. Heterogeneity was analysed using Q and I<sup>2</sup> tests. Publication bias was assessed by visual examination of funnel plot symmetry. Qualitative analysis revealed 46% of the 44 included studies showed a high risk of bias. Meta-analysis on 32 out of 44 studies revealed statistically significant intergroup differences (SSID) for VAS (SMD = −0.55; 95% CI = −0.82 to −0.27; Z = 3.90 (<i>p</i> < 0.001)), PPT (SMD = −0.45; 95% CI = −0.89 to 0.00; Z = 1.97 (<i>p</i> = 0.05)) and MMO (SMD = −0.45; 95% CI = −0.89 to 0.00; Z = 1.97 (<i>p</i> = 0.05)), favouring PBMT compared to control treatment strategies. Sensitivity analysis revealed SSID (SMD = −0.53; 95% CI = −0.73 to −0.32; Z = 5.02 (<i>p</i> < 0.0001)) with low heterogeneity (Τ<sup>2</sup> = 0.02; χ<sup>2</sup> = 16.03 (<i>p</i> = 0.31); I<sup>2</sup> = 13%). Hence, this review, for first time, proposed suggested recommendations for PBMT protocols and methodology for future extensive TMD research.https://www.mdpi.com/2076-3921/10/7/1028low-level laser therapyoxidative stressreactive oxygen speciestemporomandibular joint disorderrandomised controlled trialsphotobiomodulation
spellingShingle Reem Hanna
Snehal Dalvi
René Jean Bensadoun
Stefano Benedicenti
Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials
Antioxidants
low-level laser therapy
oxidative stress
reactive oxygen species
temporomandibular joint disorder
randomised controlled trials
photobiomodulation
title Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials
title_full Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials
title_fullStr Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials
title_full_unstemmed Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials
title_short Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials
title_sort role of photobiomodulation therapy in modulating oxidative stress in temporomandibular disorders a systematic review and meta analysis of human randomised controlled trials
topic low-level laser therapy
oxidative stress
reactive oxygen species
temporomandibular joint disorder
randomised controlled trials
photobiomodulation
url https://www.mdpi.com/2076-3921/10/7/1028
work_keys_str_mv AT reemhanna roleofphotobiomodulationtherapyinmodulatingoxidativestressintemporomandibulardisordersasystematicreviewandmetaanalysisofhumanrandomisedcontrolledtrials
AT snehaldalvi roleofphotobiomodulationtherapyinmodulatingoxidativestressintemporomandibulardisordersasystematicreviewandmetaanalysisofhumanrandomisedcontrolledtrials
AT renejeanbensadoun roleofphotobiomodulationtherapyinmodulatingoxidativestressintemporomandibulardisordersasystematicreviewandmetaanalysisofhumanrandomisedcontrolledtrials
AT stefanobenedicenti roleofphotobiomodulationtherapyinmodulatingoxidativestressintemporomandibulardisordersasystematicreviewandmetaanalysisofhumanrandomisedcontrolledtrials